Several Opportunities Lurk Within IABP Market
Date : Sep 13, 2017 Author : Sabyasachi Ghosh Category : Healthcare
Teleflex Incorporated expands its product portfolio by taking over Vascular Solutions and introduces its new Arrow AC3 Optimus IABP.
There is an increase in the acceptance of the IABP (Intra- Aortic Balloon Pump), especially in the developing regions. The countries or the emerging economies in the Asia Pacific belt, for example, China and India, can be viewed as hot areas for the intra-aortic balloon pumps from an investment standpoint, owing to rising occurrence of coronary artery diseases like unstable angina and myocardial infraction along with chronic heart diseases. The increased acceptance of the IABPs (Intra- Aortic Balloon Pumps) for carrying out the treatment of such disorders as well as using the pump for cardiogenic shock is generating ample opportunities for the intra-aortic balloon pumps.
There are other aspects which have a positive impact on the growth of adoption of the intra-aortic balloon pumps, such as improvisation in the quality of medical treatments, rising healthcare partnerships and modernization in the emerging countries etc. There are many medical device manufacturers who are striving to raise the bar of their revenue share and hence are focusing on the development of the consoles and catheters to obtain improved efficacy output and safety along with consumables like disposables and tubing which indirectly fuel the growth of the intra-aortic balloon pumps.
Moreover, the rising manufacturing activities across low-cost regions such as China, India, South Africa and other regions are favorable for the intra-aortic balloon pumps global market growth. The big players in the intra-aortic balloon pumps market are acquiring small players and increasing their global presence which in a sense encourages the use of intra-aortic balloon pumps and promotes their easy and quick availability.
Teleflex Incorporated, one of the leading providers of medical technologies for surgery, urology and critical care announced the introduction of its multifaceted PCI (Percutaneous Cardiovascular Interventions) portfolio after its acquisition of Vascular Solutions and a new intra-aortic balloon pump, called Arrow AC3 OptimusTM at the European Association for Percutaneous Cardiovascular Interventions Course or “EuroPCR” in Paris.
Teleflex had acquired Vascular Solutions to enhance its product portfolio and is able to promote new offerings – a complete line of products which offer the cardiologists working on interventional therapies all the tools which are required to manage complex as well as routine cases efficiently thereby ensuring enhanced patient outcomes. The interventional cardiologists rely on the proven effectiveness of clinical standpoint as well as a quality of the products like TrapLiner Catheter, GuideLiner Catheter Platform. R350 Guidewire, Twin-Pass Torque Dual Access Catheter, and Turnpike Catheter.
Teleflex’s new product, Arrow AC3 Optimus IABP (Intra- Aortic Balloon Pump) can help any weakened heart to pump blood and also can deliver the IABP (Intra- Aortic Balloon Pump) therapy to a wide patient range, even including those patients who were earlier not considered as candidates for the IABP (Intra- Aortic Balloon Pump) therapy. The clinicians can now use the pump on patients who are suffering from high heart rates (higher than 150 beats per minute or equal to 200 beats per minute) severe.
The new Arrow AC3 Optimus IABP has a 3rd generation Auto Pilot feature which makes use of algorithms in order to address all key clinical hindrances and challenges and simplifies the IABP therapy delivery. In this auto pilot mode, the Arrow AC3 Optimus IABP can adjust the triggering and timing parameters automatically thereby assisting the clinicians to focus on their patients instead of the pump with the help of the auto pilot mode.
Moreover, the Arrow Ac3 Optimus IABP also includes various and exclusive algorithms like WAVE Inflation Timing, Best Signal Analysis and Deflation Timing Management which assist in delivering the IABP therapy in the most challenging and critical cases by optimizing all key functions of the IABP (Intra- Aortic Balloon Pump).